X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (18) 18
Book / eBook (5) 5
Dissertation (2) 2
Publication (2) 2
Government Document (1) 1
Journal / eJournal (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
generika (23) 23
generic drugs (13) 13
medicine & public health (8) 8
drugs (7) 7
generics (6) 6
pharmaceutical industry (6) 6
arzneimittel (5) 5
drug industry (5) 5
drugs, generic (5) 5
economics (5) 5
internal medicine (5) 5
drug trade (4) 4
generic equivalents (4) 4
medicine industry (4) 4
medicine/public health, general (4) 4
medicines industry (4) 4
prescription medicine industry (4) 4
antiepileptika (3) 3
competition (3) 3
generic substitution (3) 3
gesundheitskosten (3) 3
government policy (3) 3
pharmaceutical (3) 3
pharmazeutisches produkt (3) 3
prices (3) 3
united states (3) 3
usa (3) 3
antiepileptic drugs (2) 2
arzneimittelindustrie (2) 2
arzneimittelmarkt (2) 2
bioequivalence (2) 2
biologicals (2) 2
biosimilars (2) 2
bioäquivalenz (2) 2
chemicals, rubber, drugs, biotechnology, plastics (2) 2
chemische industrie (2) 2
economic policy (2) 2
economic theory (2) 2
electronic books (2) 2
endocrinology (2) 2
entry (2) 2
family practice (2) 2
farmacología (2) 2
gastroenterology (2) 2
generic competition (2) 2
gesundheitspolitik (2) 2
health care economics and organizations (2) 2
health policy (2) 2
industria farmacéutica (2) 2
innovation (2) 2
law and legislation (2) 2
management (2) 2
markenartikel (2) 2
marketing (2) 2
medicina (2) 2
neurology (2) 2
norwegen (2) 2
patents (2) 2
pharmaceutical industry united states (2) 2
pharmaceutical policy (2) 2
pharmaceuticals (2) 2
pharmaindustrie (2) 2
pharmakonzern (2) 2
pharmazeutische industrie (2) 2
pharmazieindustrie (2) 2
pneumology/respiratory system (2) 2
political economy (2) 2
prescription decision (2) 2
produktdifferenzierung (2) 2
produktionsprozess (2) 2
rheumatology (2) 2
social sciences (2) 2
trade (2) 2
wettbewerb (2) 2
wettbewerbsbeschränkung (2) 2
"pharmacy, therapeutics, & pharmacology" (1) 1
1900-1999 (1) 1
20th cent. histories (1) 1
20th cent. history (1) 1
20th cent. history of medicine (1) 1
20th cent. medicine (1) 1
20th century histories (1) 1
20th century history (1) 1
21st cent. histories (1) 1
21st cent. history (1) 1
21st cent. history of medicine (1) 1
21st cent. medicine (1) 1
21st cent. medicines (1) 1
21st century histories (1) 1
21st century history (1) 1
advertising (1) 1
agency (1) 1
allgemeinmedizin (1) 1
allgemeinpraxis (1) 1
analysis (1) 1
anticonvulsant drugs (1) 1
apotheke (1) 1
arzneimittelmarkt / imitationswettbewerb / produktsubstitution / generika / preis / ärzte / konsumentenverhalten / gesundheitsökonomik / schätzung / deutschland. deutschland (1) 1
attitude of health personnel (1) 1
austauschbarkeit (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of generic medicines, ISSN 1741-1343, 2003
Journal
2017, ISBN 1107168481, xii, 151 pages
"While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic... 
Drugs | Generic drugs | Costs | Pharmaceutical policy | Pharmaceutical industry | Prices | United States
Book
Zeitschrift fuer Evidenz, Fortbildung und Qualitaet im Gesundheitswesen, ISSN 1865-9217, 03/2019, Volume 140, pp. 58 - 62
The main advantage of an abbreviated licensing pathway is the possibility of extrapolating efficacy and safety data from an original medicinal product to a... 
Generika | Bioäquivalenz | extrapolation | comparability exercise | generics | biosimilars | Vergleichbarkeitsstudien | bioequivalence
Journal Article
2014, ISBN 1421414937, xii, 354 pages
Reviews the history of the generic drug industry, how they attempt to market a product that purports to be exactly the same as a better known one, what are the... 
Pharmazeutische Industrie | Generic drugs | USA | History, 21st Century | Drug Industry | History, 20th Century | Generikum | history | Drugs, Generic
Book
Public Health Forum, ISSN 0944-5587, 09/2017, Volume 25, Issue 3, pp. 189 - 193
Der Arzneimittelmarkt in Deutschland ist der viertgrößte der Welt, mit einem Herstellerumsatz von knapp 32 Mrd. Euro. Die Packungsverkäufe bei den... 
Generika | Überversorgung | Biosimilars | generic drugs | oversupply | Unterversorgung | undersupply | new pharmaceutical research
Journal Article
Journal of Public Economics, ISSN 0047-2727, 2011, Volume 95, Issue 7, pp. 624 - 638
We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using a unique policy experiment in Norway,... 
Regulation | Generic competition | Pharmaceuticals | DEMAND | MARKET | PRICES | INDUSTRY | PATENT EXPIRATION | GENERIC ENTRY | INNOVATION | ECONOMICS | Pharmaceuticals Regulation Generic competition | Medical law | Generic drugs | Competition (Economics) | Analysis
Journal Article
European Economic Review, ISSN 0014-2921, 07/2013, Volume 61, pp. 116 - 131
We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we construct a theoretical model where... 
Generic substitution | Pharmaceuticals | Pharmacies | AGENCY | TRADE | PRESCRIPTION DECISION | PHYSICIAN | ENTRY | COMPETITION | ECONOMICS | Drugstores | Prices and rates | Market share | Workshops (Educational programs)
Journal Article
Zeitschrift fuer Evidenz, Fortbildung und Qualitaet im Gesundheitswesen, ISSN 1865-9217, 04/2017, Volume 121, pp. 5 - 13
Vor dem Hintergrund steigenden Kostendrucks sowie zunehmender Lieferengpässe sind Arzneimittelumstellungen zwischen wirkstoffgleichen Präparaten in Kliniken... 
Generika | patient safety | Stationäre Arzneimitteltherapie | HTA-Evaluation generischer Arzneimittel | HERA | Qualitätsmanagement | generic drugs | quality management | HTA | Health Technology Assessment | transparency | HTA (Health Technology Assessment) | Patientensicherheit | inpatient drug therapy | Transparenz
Journal Article
Zeitschrift für Rheumatologie, ISSN 0340-1855, 11/2013, Volume 72, Issue 9, pp. 873 - 877
Mit Ablauf des Patentschutzes, in Deutschland meist nach 10 Jahren, kommen für konventionelle Arzneimittel in der Regel zeitnah Generika auf den Markt, die zu... 
Generika | Tumor necrosis factor-alpha | Medicine & Public Health | Biologics | Drugs, generic | Rheumatology | Rituximab | Internal Medicine | Medikamentenzulassung | Drug approval | Biologicals | Tumornekrosefaktor-Blocker | Drugs generic
Journal Article
rheuma plus, ISSN 1868-260X, 3/2014, Volume 13, Issue 1, pp. 4 - 6
Biosimilars sind wirksamkeitsäquivalente Nachfolgeprodukte von etablierten biologisch hergestellten Medikamente (z. B. Immunsuppressiva). Nach sorgfältiger... 
Generika | Rheumatoide Arthritis | Nachahmerprodukte | Medicine & Public Health | Rheumatology | Medikamente | Biologicals
Journal Article
Technisches Messen, ISSN 0171-8096, 2014, Volume 81, Issue 6, pp. 289 - 295
Journal Article
2016, Munich Studies on Innovation and Competition, ISBN 9783662496541, Volume 4, 269
This book explores the concept of test data exclusivity protection for pharmaceuticals. Focusing on Art 39(3) of the WTO Agreement on Trade-Related Aspects of... 
Law and economics | Private International Law, International & Foreign Law, Comparative Law | Law and Economics | Law | International Economic Law, Trade Law | International IT and Media Law, Intellectual Property Law | Drugs | Intellectual property
eBook
Nervenheilkunde, ISSN 0722-1541, 2009, Volume 28, Issue 6, pp. 399 - 402
Journal Article
2014, 2015, SpringerBriefs in Political Science, ISBN 9783319125640, Volume 26, 126
Brazil is renowned worldwide for its remarkable reforms in pharmaceutical regulation, which have enhanced access to essential medicines while lowering drug... 
Pharmaceutical policy | Brazil | Economics/Management Science | Economic Policy | Political Economy | Social Policy
eBook
Wiener klinische Wochenschrift, ISSN 0043-5325, 2/2008, Volume 120, Issue 3, pp. 63 - 69
Since the introduction of generic drugs to the pharmaceutical market a sometimes emotional debate exists whether they are well-investigated and of high... 
Generika | Chemische Qualität | Bioequivalence | Pharmaceutical quality | Internal Medicine | Medicine/Public Health, general | Generic drugs | Bioäquivalenz | Pneumology/Respiratory System | Medicine & Public Health | Zulassung | Gastroenterology | Marketing authorisation | Interchangeability | Endocrinology | Austauschbarkeit
Journal Article
Wiener klinische Wochenschrift, ISSN 0043-5325, 2/2008, Volume 120, Issue 3, pp. 89 - 95
BACKGROUND: Rising costs of pharmaceuticals are a challenge to the public health care system. In collaboration with a company health insurance with 3143... 
Health care | Generika | Pharmakoökonomie | Internal Medicine | Gesundheitssystem | Medicine/Public Health, general | Generic drugs | Pneumology/Respiratory System | Medicine & Public Health | Gastroenterology | Rückerstattung | Pharmacoeconomics | Reimbursement | Endocrinology
Journal Article
Wiener Medizinische Wochenschrift, ISSN 0043-5341, 4/2009, Volume 159, Issue 7, pp. 196 - 201
Journal Article
Medizinische Klinik, ISSN 0723-5003, 9/2006, Volume 101, Issue 9, pp. 705 - 710
Gesundheitsökonomisch ist eine weitgehende Umstellung von Originalpräparaten auf Generika sinnvoll und erwünscht. Es gibt bisher kaum Daten darüber, ob und... 
Generika | Einstellung zu Medikamenten | Internal Medicine | Medicine/Public Health, general | Medicine & Public Health | Family physician | Verordnungsverhalten | Generic prescribing | Hausarzt | Attitude of health personnel | Interprofessional relations | Allgemeinpraxis | Kollegiale Zusammenarbeit | Family practice
Journal Article
04/2011, ISBN 1611220718
Book
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.